Notre Dame’s WFCDD grant supports collaborative, multidisciplinary drug discovery research with access to advanced facilities for chemical synthesis, screening, and computational drug design for a range of human diseases.
Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.
Technology Bridge Fund supports researchers with studies addressing reviewer feedback on external grant proposals, encouraging resubmission of research with potential to advance precision health.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
Technology Initiator Fund supports researchers developing early-stage technologies, from molecular detection to wearable sensing, with significant potential to advance precision health.
Drug Discovery Postdoctoral Fellowship supports postdoctoral researchers’ early-stage drug discovery training to advance therapeutically relevant science with clear potential for translation to humans.